Stone House Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22
Closed -$369 1356
2026
Q1
$369 Buy
+22
New +$394 ﹤0.01% 857

Other funds holding CLB

Stone House Investment Management's CLB Position: Q2 2026 in Review

Stone House Investment Management sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 22 shares — an estimated $369 sold.

Stone House Investment Management first reported a position in CLB in Q1 2026 and held it in 1 quarter. The position peaked at $369 in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Stone House Investment Management reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Stone House Investment Management sold 22 Core Laboratories shares in Q2 2026, an estimated $369.
  • Stone House Investment Management first reported a position in Core Laboratories in Q1 2026 and held it in 1 quarter.
  • Stone House Investment Management's Core Laboratories position peaked at $369 in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.